Position in TECH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$59,124,865
+$14,296,765 QoQ
Shares Held
836,870
+3.9% QoQ
Ownership
0.534%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#42
of 592 holders
Holding Since
Dec 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Balyasny Asset Management L.P. holds $2,351,657,469 across 178 Biotechnology names. TECH ranks #9 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
1,665,102 | $221,008,988 | |
| 2 | INSM |
INSMED Inc
|
1,326,430 | $141,423,966 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,230,052 | $91,614,272 | |
| 4 | ABVX |
Abivax S.A.
|
603,840 | $80,467,718 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
145,005 | $72,028,333 | |
| 6 | TNGX |
Tango Therapeutics, Inc.
|
2,016,379 | $63,032,007 | |
| 7 | CYTK |
Cytokinetics Inc
|
711,676 | $60,627,678 | |
| 8 | BMRN |
Biomarin Pharmaceutical Inc
|
1,054,613 | $60,344,955 |
All Filings in TECH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,124,865 | 836,870 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $44,828,100 | 805,826 | Shares | Sole | 2025-11-14 | |
| 2024-12-31 | $3,390,380 | 47,069 | Shares | Sole | 2025-02-14 | |
| 2023-06-30 | $34,425,084 | 421,721 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $39,699,438 | 535,105 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $326,049 | 3,934 | Shares | Other | 2023-02-14 | |
| 2022-06-30 | $27,173,109 | 78,390 | Shares | Sole | 2022-08-15 | |
| 2020-12-31 | $903,112 | 2,844 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||